Condition: Asthma
Interventions: Drug: NVA237; Drug: Placebo to NVA237; Drug: salbutamol/ albuterol
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days